HealthTree Logo
search more_vert
App Logo
close
person Sign In / Create Account
Myeloma News

Breaking Headlines

Investing Trust, Seeking Solutions: The HealthTree Foundation Today

Dec. 04, 2022

Investing Trust, Seeking Solutions: The HealthTree Foundation Today

Clinical Trial: Assessing Glutamine Metabolism in MGUS and Myeloma

Nov. 30, 2022

Clinical Trial: Assessing Glutamine Metabolism in MGUS and Myeloma

Managing the Caregiver Roles: Chef, Chauffeur, Secretary, and Many More

Nov. 30, 2022

Managing the Caregiver Roles: Chef, Chauffeur, Secretary, and Many More

Donate to Multiple Myeloma Research Today, Giving Tuesday

Nov. 29, 2022

Donate to Multiple Myeloma Research Today, Giving Tuesday

HealthTree Resources Support Survivorship

Nov. 29, 2022

HealthTree Resources Support Survivorship

HealthTree Accelerates Research

Nov. 28, 2022

HealthTree Accelerates Research

The Impact of Diet on MRD-Negativity in Multiple Myeloma

Nov. 24, 2022

The Impact of Diet on MRD-Negativity in Multiple Myeloma

The Role of Maintenance Therapy After Stem Cell Transplant

Nov. 23, 2022

The Role of Maintenance Therapy After Stem Cell Transplant

Clinical Trial: Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-American Patients

Nov. 22, 2022

Clinical Trial: Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-American Patients

What GSK's BLENREP Change Means for US Myeloma Patients

Nov. 22, 2022

What GSK's BLENREP Change Means for US Myeloma Patients

How It All Began: HealthTree for Multiple Myeloma

Nov. 21, 2022

How It All Began: HealthTree for Multiple Myeloma

The Best Simple Vegan Potato Salad

Nov. 21, 2022

The Best Simple Vegan Potato Salad

Recent Articles

New in Myeloma

What GSK's BLENREP Change Means for US Myeloma Patients image
What GSK's BLENREP Change Means for US Myeloma Patients
Redefining the Diagnosis for Plasma Cell Leukemia? image
Redefining the Diagnosis for Plasma Cell Leukemia?
First Bispecific Antibody, Teclistamab, Now FDA Approved in Multiple Myeloma image
First Bispecific Antibody, Teclistamab, Now FDA Approved in Multiple Myeloma
Carvykti: Solving Capacity Issues? image
Carvykti: Solving Capacity Issues?
Promising Outcomes of Sequential T-cell Redirection Salvage Therapy After Relapse of Multiple Myeloma image
Promising Outcomes of Sequential T-cell Redirection Salvage Therapy After Relapse of Multiple Myeloma
Predicting Neurotoxicities Prior to CAR-T Treatment in Multiple Myeloma image
Predicting Neurotoxicities Prior to CAR-T Treatment in Multiple Myeloma
Load More

Life With Myeloma

Managing the Caregiver Roles: Chef, Chauffeur, Secretary, and Many More image
Managing the Caregiver Roles: Chef, Chauffeur, Secretary, and Many More
Donate to Multiple Myeloma Research Today, Giving Tuesday image
Donate to Multiple Myeloma Research Today, Giving Tuesday
HealthTree Resources Support Survivorship image
HealthTree Resources Support Survivorship
The Impact of Diet on MRD-Negativity in Multiple Myeloma image
The Impact of Diet on MRD-Negativity in Multiple Myeloma
Make a difference this Giving Tuesday image
Make a difference this Giving Tuesday
The Many Different Manifestations of MGUS image
The Many Different Manifestations of MGUS
Load More

Myeloma Basics

The Role of Maintenance Therapy After Stem Cell Transplant image
The Role of Maintenance Therapy After Stem Cell Transplant
The Personal Impact of a HealthTree Coach: Maddie & Renee's Story image
The Personal Impact of a HealthTree Coach: Maddie & Renee's Story
What Are Neutrophils in Multiple Myeloma? image
What Are Neutrophils in Multiple Myeloma?
Different Types of CAR-T in Multiple Myeloma image
Different Types of CAR-T in Multiple Myeloma
Why Use a Myeloma Specialist? image
Why Use a Myeloma Specialist?
What Is the Response Rate of CAR-T Cell Therapy? image
What Is the Response Rate of CAR-T Cell Therapy?
Load More
Research
articles for Research
Clinical Trials
articles for Clinical Trials
HealthTree Press
articles for HealthTree Press
HealthTree
articles for HealthTree
Healthy Recipes
articles for Healthy Recipes

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Abbvie
Genentech
GSK
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube

 https://www.guidestar.org/profile/45-5354811

HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization.

Copyright © 2022 HealthTree Foundation. All rights reserved.

Tax ID 45-5354811